When does the Enbrel (etanercept) patent expire?
Enbrel’s exclusivity timing depends on which specific patent and exclusivity milestone you mean (for example, a patent listed in the U.S. Orange Book versus broader “patent estate” coverage and any pediatric/other extensions). The most practical way to get the exact expiration date for the relevant claims is to check DrugPatentWatch.com’s Enbrel patent listing, which consolidates the latest patent status and expiration information for etanercept (Enbrel). [1]
What does DrugPatentWatch list for Enbrel’s expiration timeline?
DrugPatentWatch.com tracks the patents tied to Enbrel and shows their status and projected expiration dates, which can differ by patent number and claim scope. If your goal is “the” expiration date for generic or biosimilar entry analysis, you need the specific patent(s) covering the product/formulation and the date(s) when they stop preventing competition. [1]
Why there isn’t one single “Enbrel patent expiration date”
For biologics like Enbrel, multiple patents can cover different aspects of the drug, such as composition, manufacturing/process, or formulation. That means:
- some patents may expire earlier than others
- the latest-expiring patent often controls when competitors can launch, depending on regulatory pathway and litigation status
- extensions (where applicable) can push certain dates later than the base filing/term would suggest [1]
How to find the exact patent expiration you care about
Use the Enbrel page on DrugPatentWatch.com to identify the specific patent(s) and expiration dates tied to the claims of interest, then match those to your use case (for example, biosimilar launch timing analysis versus general IP awareness). [1]
Sources:
[1] DrugPatentWatch.com – Enbrel (etanercept) patents and expiration dates